Literature DB >> 23706496

Diagnosis and treatment of tuberculous uveitis in a low endemic setting.

A G Vos1, M W M Wassenberg, J de Hoog, J J Oosterheert.   

Abstract

OBJECTIVE: To determine factors associated with the diagnosis of tuberculous uveitis and the response to anti-tuberculous treatment (ATT).
METHODS: A retrospective case study was performed at the University Medical Centre Utrecht between October 2007 and December 2009. Patients with possible tuberculous uveitis (TBU) were selected from all patients with an unexplained uveitis. Demographics, ethnicity, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tuberculin skin test (TST), QuantiFERON (QFT) test, and ocular findings were evaluated. An interdisciplinary panel discussed if there was a presumed TBU and decided to start treatment. When there was a decrease in intraocular cell count and/or improvement in visual acuity after ATT, the confirmation of presumed TBU was made.
RESULTS: Of 585 patients with unexplained uveitis, 66 (11.3%) fulfilled the definition of possible TBU. Ten (15.4%) patients were regarded as having presumed TBU and received ATT. All of them had latent tuberculosis (LTB). The ocular situation improved in seven patients (70%). A history of TB contact, abnormalities on chest radiology, and extraocular manifestations of TB were associated with a good response to ATT in the case of presumed tuberculous uveitis.
CONCLUSIONS: Tuberculous uveitis remains difficult to diagnose. No clearly correlating factors that predicted the response to ATT, including ocular parameters, could be identified.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Latent tuberculosis; Tuberculosis; Uveitis

Mesh:

Substances:

Year:  2013        PMID: 23706496     DOI: 10.1016/j.ijid.2013.03.019

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  10 in total

1.  MTBDRplus for the rapid diagnosis of ocular tuberculosis and screening of drug resistance.

Authors:  K Sharma; A Gupta; M Sharma; A Sharma; R Singh; K Aggarwal; R Bansal; A Thakur; S Prakash; V Gupta
Journal:  Eye (Lond)       Date:  2017-10-20       Impact factor: 3.775

2.  Ophthalmic Presentation of Disseminated Tuberculosis with Relapse-Immunological Profile.

Authors:  Bineeta Kashyap; Nisha Goyal; G K Das; N P Singh; I R Kaur
Journal:  Indian J Clin Biochem       Date:  2018-02-21

3.  Ocular Tuberculosis--A Clinical Conundrum.

Authors:  Cecilia Lee; Rupesh Agrawal; Carlos Pavesio
Journal:  Ocul Immunol Inflamm       Date:  2015-06-25       Impact factor: 3.070

Review 4.  Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis.

Authors:  Ae Ra Kee; Julio J Gonzalez-Lopez; Aws Al-Hity; Bhaskar Gupta; Cecilia S Lee; Dinesh Visva Gunasekeran; Nirmal Jayabalan; Robert Grant; Onn Min Kon; Vishali Gupta; Mark Westcott; Carlos Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-03-10       Impact factor: 6.048

5.  QuantiFERON-TB Gold Assay on Plasma for Confirmation of Presumed Tuberculosis-Related Uveitis.

Authors:  Stefania Zanetti; Alessandra Bua; Paola Molicotti; Irene Maiore; Antonio Pinna
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948

6.  Review of people with retinal vasculitis and positive QuantiFERON®-TB Gold test in an area nonendemic for tuberculosis.

Authors:  David R Brunner; Sandrine A Zweifel; Daniel Barthelmes; Fabio Meier; Christian Böni
Journal:  Int Ophthalmol       Date:  2017-10-13       Impact factor: 2.031

7.  Contribution of Dual Fluorescein and Indocyanine Green Angiography to the Appraisal of Presumed Tuberculous Chorioretinitis in a Non-endemic Area.

Authors:  Raphael Massy; Carl P Herbort
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

8.  Treatment Outcome of Tubercular Uveitis in a High TB and HIV Setting: A Prospective Cohort Study.

Authors:  Hassan Dawood Alli; Naseer Ally; Ismail Mayet; Lavania Joseph; Shaheed Omar; Shabir Madhi
Journal:  Clin Ophthalmol       Date:  2021-12-30

9.  Type 1 interferon-inducible gene expression in QuantiFERON Gold TB-positive uveitis: A tool to stratify a high versus low risk of active tuberculosis?

Authors:  Rina La Distia Nora; Ratna Sitompul; Marleen Bakker; Marjan A Versnel; Sigrid M A Swagemakers; Peter J van der Spek; Made Susiyanti; Lukman Edwar; Soedarman Sjamsoe; Gurmeet Singh; Rr Diah Handayani; Aniki Rothova; P Martin van Hagen; Willem A Dik
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

10.  Tuberculous Uveitis, Erythema Induratum, and Persistent Genital Warts in a Female Patient: A Rare Case Report.

Authors:  Mohammad Mahdi Majzoobi; Siamak Akbarzadeh; Golnoush Ebrahimi; Hamid Reza Ghasemibasir; Pedram Alirezaei
Journal:  Adv Biomed Res       Date:  2019-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.